Tonix Pharmaceuticals Holding Corp.
TNXP
$38.00
$2.156.00%
NASDAQ
06/30/2025 | 03/31/2025 | ||||
---|---|---|---|---|---|
Revenue | -17.74% | -5.93% | |||
Total Other Revenue | -- | -- | |||
Total Revenue | -17.74% | -5.93% | |||
Cost of Revenue | 246.98% | -20.29% | |||
Gross Profit | -185.73% | 6.22% | |||
SG&A Expenses | 60.35% | -35.16% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | 63.90% | -26.25% | |||
Operating Income | -76.26% | 28.59% | |||
Income Before Tax | -68.00% | 23.88% | |||
Income Tax Expenses | -- | -- | |||
Earnings from Continuing Operations | -68.00% | 23.88% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | -68.00% | 23.88% | |||
EBIT | -76.26% | 28.59% | |||
EBITDA | -80.31% | 27.65% | |||
EPS Basic | -35.90% | 70.93% | |||
Normalized Basic EPS | -55.18% | 74.54% | |||
EPS Diluted | -35.90% | 70.93% | |||
Normalized Diluted EPS | -55.18% | 74.54% | |||
Average Basic Shares Outstanding | 23.62% | 161.86% | |||
Average Diluted Shares Outstanding | 23.62% | 161.86% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |